Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Keith N. Hylton
European Commission Decision on Intel Statement by Boston University Law Professor Keith N. Hylton
May 31st, 2009
Keith N. Hylton, the Honorable Paul J. Liacos Professor of Law at Boston University School of Law, issued the following statement in reaction to the European Commission's ruling on the investigation of Intel's business practices. "The EC decision to impose the largest fine in its history on Intel, largely for its price cutting, sends a worrisome signal to dominant firms in the U.S. Antitrust law in the U.S. has largely abandoned the idea that consumers can be made better off by punishing firms that cut prices aggressively," said Professor Hylton. "Punishing large firms for cutting prices provides a strong incentive for those firms to avoid price competition, and this...
Source: Pharma Investments, Ventures & Law Weekly (2009-05-31)
|
